These studies indicate that host tissues are inhibited by extremely low concentrations of methotrexate, and indicate the importance of the slow final phase (ti = 12 h) of drug elimination from plasma in producing a prolonged exposure of sensitive host tissues to inhibitory drug concentrations.
A B S T R A C
METHODS Methotrexate concentrations. Methotrexate concentrations in plasma and ascites were determined by the dihydrofolate reductase inhibition assay as described by Bertino and Fischer (5). Dihydrofolate reductase purified by affinity chromatography (6) from L1210 leukemia cells and of specific activity 200 U/mg protein was used in the assay. The lower limit of sensitivity of this assay is 2 X 10' M methotrexate in the assay cuvette. This sensitivity allows determination of plasma methotrexate levels as low as 1 X 10-9 M.
['H]UdR incorporation studies.
['H]UdR (1.9 Ci/mmol) was obtained from New England Nuclear, Boston, Mass. 100 4sCi was injected i.p. into male BDF1 mice weighing 18-23 g, and at specified time intervals, animals were killed by cervical dislocation. A 5-cm segment of duodenum was obtained and slit longitudinally; the epithelium was stripped from the underlying muscularis by firm scraping with the edge of a glass microscopic slide and dispersed in iced phosphate-buffered saline. Bone marrow cells were removed from the tibias by inserting a hypodermic needle into one end of the medullary cavity and expelling the marrow content with a jet of iced buffered saline. In tumor-bearing mice, ascitic L1210 leukemia cells were obtained by lavage of the peritoneal cavity with iced buffered saline. DNA was extracted from each tissue specimen by the method of Schneider (7) . A portion of the final supernate was dissolved in Aquasol (New England Nuclear) for measurement of 'H radioactivity in the DNA, and a second portion was used for determination of the concentration of DNA by Burton's method (8) . Results were expressed as counts per minute 'H per microgram DNA.
Preliminary studies of ['H]UdR incorporation into DNA
in both normal and tumor-bearing animals indicated that deoxynucleoside incorporation in both bone marrow and duodenal mucosa increased linearly for 20 min after isotope injection before approaching a maximum value at 1 h, and declining slowly thereafter ( by cervical dislocation. Plasma for methotrexate determination was obtained by cardiac puncture. Bone marrow, duodenal mucosa, and ascitic cells from the three animals in each group were pooled for determination of [ Other experimental evidence supports the concept that the persistence of low levels of methotrexate is responsible for host toxicity. Previous work from this laboratory has shown that the toxicity of otherwise lethal doses of methotrexate may be prevent by administration of a methotrexate-metabolizing enzyme, carboxypeptidase G1, 24 h after the antifolate (11) . In this instance, rescue from methotrexate toxicity was associated with eliminating low levels of residual methotrexate, less than 10-' M, from extracellular fluid without affecting the established intracellular blockade of dihydrofolate reductase. Additional corroboration was furnished by Zaharko and Dedrick (12) , who showed that repeated small doses of methotrexate, maintaining plasma methotrexate at 10-' M for 30 h, were capable of producing lethal toxicity. Margolis, et al., (4) also found that a close relationship existed between the duration of inhibition of DNA synthesis in mouse intestine and the presence of free intracellular methotrexate after doses of 0.5, 5.0, and 50 mg/kg. However, plasma methotrexate levels below 10-' M (50 ng/ml) were not defined in their study, and the relationship of recovery of DNA synthesis to plasma methotrexate was not established.
These findings are entirely in keeping with current knowledge of methotrexate's pharmacologic action as (14) . Secondly, cellular uptake of methotrexate has been shown to take place by an active transport mechanism shared by certain other folates (15) , including the predominant circulating compound, 5-methyl tetrahydrofolic acid, which in mice is present in concentrations of 10-' M (16) . Lesser concentration of methotrexate might thus be excluded from transport by the endogenous folates.
The delay in recovery of duodenal mucosa as compared to bone marrow observed in this study is consistent with previous work that showed that the lethality of high doses of the antifolate in mice is due to intestinal denudation rather than myelosuppression (17) . This delay may indicate a greater sensitivity of intestinal mucosa or may result from the enterohepatic circulation of the drug, which produces a higher concentration of methotrexate in the lumen of small intestine as compared to plasma (18) . Whether intraluminal methotrexate affects DNA synthesis in the intestinal crypts, where most reproductive activity takes place, is not known.
The effects of methotrexate on ascitic L1210 cells differed from that seen in host tissues. The duration of inhibition of [3H]UdR incorporation in the L1210 cells was related to dose, but the initial recovery peak did
